Pure Global
NCT06264128

TPAP for Comfort in OSA

The Effect on Subjective Comfort of a Device Providing Positive Airway Pressure (PAP) Drops During Inspiration (TPAP) Compared to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea Patients
SleepRes Inc.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Drug/Device/Intervention
TPAP
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
SleepRes Inc.
Location
Murfreesboro, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2024
End date
Jun 30, 2024
Enrollment
80 participants
Primary outcome

CPAP v TPAP Patient Preference via Visual Analog Scale

Summary

TheraPAP is a prototype device (with full documented electrical and isolation safety) being
 developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver
 either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control
 algorithm that lowers the pressure from the set pressure at the beginning of inspiration and
 does not return the pressure to the full set level until about halfway through expiration.
 The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort
 vs. CPAP during supine wakefulness.

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06264128
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06264128 through Pure Global AI's free database. This phase not specified trial is sponsored by SleepRes Inc. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.